Astragaloside IV from Astragalus membranaceus Shows Cardioprotection during Myocardial Ischemia in vivo and in vitro

Abstract

Astragaloside IV is the major active constituent of Astragalus membranaceus, which has been widely used for the treatment of cardiovascular diseases in China. However, the effects of astragaloside IV on myocardial ischemia and its mechanisms of action remain largely unknown. In this study, we have examined the effects of astragaloside IV on myocardial infarction and coronary flow in vivo and in vitro. The possible roles of its antioxidative and nitric oxide-inducing properties were also explored. Astragaloside IV significantly reduced infarct size in dogs subjected to coronary ligation in vivo. Astragaloside IV also improved post-ischemic heart function and ameliorated reperfusion arrhythmias in rat hearts in vitro. The cardioprotection of astragaloside IV was accompanied by a significant increase in coronary flow both in vivo and in vitro. The nitric oxide synthase inhibitor, N^ω -nitro-L-arginine methyl ester partially abrogated astragaloside IV’s protective effect on heart function. Myocardial antioxidative enzyme superoxide dismutase activity increased with astragaloside IV administration. These data suggest the potential roles of antioxidative and nitric oxide-inducing properties of astragaloside IV in its protection from myocardial ischemia.

Key words

Astragaloside IV - ischemia - cardioprotection - nitric oxide - superoxide dismutase

References

• 1 Li S Q, Yuan R X, Gao H, Wang Y Q. Clinical observation on treatment of ischemic heart disease with Astragalus membranaceus .  Chin J Integr Trad Western Med. 1995;  15 77-80
• 2 Miller A L. Botanical influences on cardiovascular disease.  Altern Med Rev. 1998;  3 422-31
• 3 Zhou S, Shao W, Wang W. Clinical study of Astragalus injection plus ligustrazine in protecting myocardial ischemia reperfusion injury.  Chin J Integr Trad Western Med. 2000;  20 504-7
• 4 Sun C W, Lü W W, Lei C L, Wu Y, Chen Y. Effects of Astragalus saponins on experimental heart failure.  J N Berthune Univ Med School. 1994;  20 125-7
• 5 Zhou J Y, Fan Y, Kong J L, Wu D Z, Hu Z B. Effects of components isolated from Astragalus membranaceus Bunge on cardiac function injured by myocardial ischemia reperfusion in rats.  China J Chin Mater Medica. 2000;  25 300-2
• 6 Wang H K, He K, Ye J L. Chemical constituents of Astragalus mongholicus .  Chin Tradit Herb Drugs. 1987;  18 5-7
• 7 Ji X, Tan B K, Zhu Y C, Linz W, Zhu Y Z. Comparison of cardioprotective effects using ramipril and DanShen for the treatment of acute myocardial infarction in rats.  Life Sci. 2003;  73 1413-26
• 8 Chen L B, Liu T, Wu J X, Chen X F, Wang L, Fan C L. et al . Hypertonic perfusion reduced myocardial injury during subsequent ischemia and reperfusion in normal and hypertensive rats.  Acta Pharmacol Sin. 2003;  24 1077-82
• 9 Curtis M J, Walker M J. Quantification of arrhythmia using scoring systems: an examination of seven scores in an in vivo model of regional myocardial ischaemia.  Cardiovasc Res. 1988;  22 656-65
• 10 Shi G G, Chen J C, Li Z C, Liu X P. Direct effect of Astragalus membranaceus on coronary artery.  Trad Chin Drug Res Clin Pharmacol. 1999;  10 38-9
• 11 Michel T, Feron O. Nitric oxide: which, where, how and why?.  J Clin Invest. 1997;  100 2146-52
• 12 Nathan C. Inducible nitric oxide synthase: what difference does it make?.  J Clin Invest. 1997;  100 2417-24
• 13 Koboki K, Jiang Z Y, Takahara N, Ha S W, Igarashi M, Yamauchi T. et al . Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo .  Circulation. 2000;  101 676-81
• 14 Wang P, Zweier J L. Measurement of nitric oxide and peroxynitrite generation in the postischemic heart.  J Biol Chem. 1996;  271 29 223-30
• 15 Ma X L, Weyrich A S, Lefer D J, Lefer A M. Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium.  Circ Res. 1993;  72 403-12
• 16 Rochetaing A, Kreher P. Reactive hyperemia during early reperfusion as a determinant of improved functional recovery in ischemic preconditioned rat hearts.  J Thorac Cardiovasc Surg. 2003;  125 1516-25
• 17 Beckman J S, Koppenol W H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad and ugly.  Am J Physiol. 1996;  271 C1424-C37
• 18 Kobara M, Tatsumi T, Takeda M, Mano A, Yamanaka S, Shiraishi J. et al . The dual effects of nitric oxide synthase inhibitors on ischemia-reperfusion injury in rat hearts.  Basic Res Cardiol. 2003;  98 319-28
• 19 Narang D, Sood S, Thomas M K, Dinda A K, Maulik S K. Effect of dietary palm olein oil on oxidative stress associated with ischemic-reperfusion injury in isolated rat heart.  BMC Pharmacol. 2004;  4 29
• 20 Ostadal P, Elmoselhi A B, Zdobnicka I, Lukas A, Elimban V, Dhalla N S. Role of oxidative stress in ischemia-reperfusion-induced changes in Na⁺, K⁽⁺⁾-ATPase isoform expression in rat heart.  Antioxid Redox Signal. 2004;  6 914-23
• 21 Gupta S K, Mohanty I, Talwar K K, Dinda A, Joshi S, Bansal P. et al . Cardioprotection from ischemia and reperfusion injury by Withania somnifera: a hemodynamic, biochemical and histopathological assessment.  Mol Cell Biochem. 2004;  260 39-47
• 22 Ma Z, Yang Z. Scanvenging effects of Astragalus and Gynostemma pentaphyllum with its products on O₂ ^- and OH.  J Chin Med Mat. 1999;  22 303-6
• 23 Luo Y, Qin Z, Hong Z, Zhang X, Ding D, Fu J H. et al . Astragaloside IV protects against ischemic brain injury in a murine model of transient focal ischemia.  Neurosci Lett. 2004;  363 218-23

1 The first two authors contribute equally to the work of this paper